Corrigendum to “Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory biopsy study” [Eur. J. Radiol. Open 11 (2023) 100529]

Documenti analoghi

• Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory biopsy study
  di: Jyothirmayi Velaga, et al.
  Pubblicazione: (2023-12-01)
• Correlation between Gleason score and PIRADS score on mpMRI –initial experience
  di: M. Parameswaran, et al.
  Pubblicazione: (2020-11-01)
• Assessing the value of mpMRI PIRADS lesions in the transitional zone: Analysis of a single center repeat biopsy cohort
  di: L. Sarchi, et al.
  Pubblicazione: (2020-01-01)
• Mischievous malakoplakia: A potential pitfall of mpMRI of the prostate?
  di: Michael E. Rezaee, et al.
  Pubblicazione: (2020-09-01)
• Which men should undergo non-targeted systematic sampling in an mpMRI-targeted pathway – an analysis from 1,719 pre-biopsy mpMRI cases?
  di: M.J. Connor, et al.
  Pubblicazione: (2020-07-01)